Evaxion Biotech AS (EVAX)
4.02
+0.11
(+2.81%)
USD |
NASDAQ |
May 02, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
Evaxion Biotech Market Cap: 20.96M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 20.39M |
| April 30, 2024 | 21.75M |
| April 29, 2024 | 22.37M |
| April 26, 2024 | 21.80M |
| April 25, 2024 | 21.49M |
| April 24, 2024 | 21.54M |
| April 23, 2024 | 21.59M |
| April 22, 2024 | 21.85M |
| April 19, 2024 | 22.48M |
| April 18, 2024 | 22.01M |
| April 17, 2024 | 21.43M |
| April 16, 2024 | 21.07M |
| April 15, 2024 | 21.38M |
| April 12, 2024 | 21.38M |
| April 11, 2024 | 20.29M |
| April 10, 2024 | 20.81M |
| April 09, 2024 | 20.65M |
| April 08, 2024 | 21.33M |
| April 05, 2024 | 19.24M |
| April 04, 2024 | 19.04M |
| April 03, 2024 | 18.77M |
| April 02, 2024 | 20.23M |
| April 01, 2024 | 16.84M |
| March 28, 2024 | 16.69M |
| March 27, 2024 | 15.65M |
| Date | Value |
|---|---|
| March 26, 2024 | 16.32M |
| March 25, 2024 | 16.17M |
| March 22, 2024 | 15.91M |
| March 21, 2024 | 15.91M |
| March 20, 2024 | 15.80M |
| March 19, 2024 | 16.01M |
| March 18, 2024 | 16.06M |
| March 15, 2024 | 15.59M |
| March 14, 2024 | 14.19M |
| March 13, 2024 | 14.58M |
| March 12, 2024 | 14.53M |
| March 11, 2024 | 15.01M |
| March 08, 2024 | 14.92M |
| March 07, 2024 | 14.15M |
| March 06, 2024 | 13.95M |
| March 05, 2024 | 14.53M |
| March 04, 2024 | 15.35M |
| March 01, 2024 | 16.31M |
| February 29, 2024 | 17.32M |
| February 28, 2024 | 17.61M |
| February 27, 2024 | 17.32M |
| February 26, 2024 | 18.09M |
| February 23, 2024 | 18.19M |
| February 22, 2024 | 18.43M |
| February 21, 2024 | 18.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
13.27M
Minimum
Sep 19 2023
243.44M
Maximum
Nov 04 2021
67.92M
Average
52.27M
Median
Nov 30 2022
Market Cap Benchmarks
| Ascendis Pharma A/S | 7.999B |
| DBV Technologies SA | 130.52M |
| Cellectis SA | 214.42M |
| Adaptimmune Therapeutics PLC | 294.96M |
| Akari Therapeutics PLC | 11.65M |
Market Cap Related Metrics
| Price | 4.02 |
| Earnings Yield | -201.5% |